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Introduction
The human endometrium, a typical target tissue of ovarian steroid hormones, is regulated by oestrogen and progesterone, and undergoes a cycle of proliferation, differentiation and desquamation. Under the influence of these hormones and in the presence of the trophoblast, the endometrium is transferred into the decidua. The function of the decidua has not been clearly defined but suggested functions include a role in the implantation and nutrition of the blastocyst and in the immunological separation of maternal and fetal tissues. Cyclic nucleotides that may have various physiological roles are present in the endometrium and the decidua, and are modulated by steroid hormones in the human endometrium (Bergamini et al., 1985) , human decidua (Whitsett and Johnson, 1979) , rabbit endometrium and decidua (Bekairi et al, 1984; Fortier et al, 1987 Fortier et al, , 1990 ) and other tissues. We have reported that multiple protein kinases, particularly types I and II cAMPdependent protein kinases, are regulated by oestrogen and pro¬ gesterone in human and rabbit endometria via de novo synthesis (Miyazaki et al, 1980a,b) . Furthermore, it has been demon¬ strated that phosphorylation mediated by cyclic nucleotides may be involved in the regulation of steroid hormone receptor binding (Fleming et al, 1983) , the control of intracellular free calcium (Reuter, 1983) and sodium (Costa et al, 1982) concen¬ trations. Significant quantities of prostaglandins (PGs) (Singh et al, 1975) and catecholamines (Dujovne et al, 1976) (Bhalla et al, 1972) , rat (Vesin et al, 1978) and human (Bergamini et al, 1985) endometria. Bergamini et al (1985) demonstrated that endometrial adenylyl cyclase activity was stimulated by sodium fluoride and 5'guanylyl imidodiphosphate (Gpp(NH) (Brundin and Wirsen, 1964) . The theca extema of the Graafian follicle con¬ tains numerous cholinergic nerves (Stefenson et al, 1981) , and adrenergic nerve terminals are seen in the wall of the whole Graafian follicle (Owman et al, 1975) . Catecholamines are thought to play an important role in the ovary (Weiss et al, 1982; Wheeler et al, 1987) and in the Fallopian tube (Dujovne et al, 1976 (Powell et al, 1974) . PGs evoke myometrial contractions in women (Karim et al, 1968) , and regulate oviduct motility (Spilman, 1974 (Fig. 2) .
Forskolin-stimulated adenylyl cyclase activity (Fig. 3a) rapidly increased after ovulation, reached a peak during the early secretory phase and maintained this value up to the late secretory phase. Forskolin-stimulated adenylyl cyclase activity in the early, mid-and late secretory phases was significantly higher (P < 0.01) than in the early proliferative phase. Forskolin appeared to be the most potent activator of adenylyl cyclase activity among the agents tested. In contrast, NaFstimulated activity decreased slightly, but not significantly, from the proliferative phase to the secretory phase of the menstrual cycle (Fig. 3b) .
Isoproterenol-and adrenaline-stimulated activities were highest in the late proliferative phase and significantly decreased thereafter. Isoproterenol-stimulated adenylyl cyclase activity was significantly higher (P < 0.01) during the late proliferative and the early secretory phases than in the late secretory phase (Fig. 4a) . Adrenaline-stimulated adenylyl cyclase activity was significantly higher (P < 0.05) during the late proliferative phase than in the late secretory phase. Noradrenaline, however, produced almost no alteration in adenylyl cyclase activity throughout the menstrual cycle (data not shown).
The changes in the sensitivity of the dose-response curve during the menstrual cycle were investigated by comparing the concentration giving the half-maximal response (EC50) for each of the agents used in this study during the most sensitive and insensitive phases of the menstrual cycle. Each agent stimulated endometrial activity in a dose-dependent manner and maximum stimulation was seen at concentrations of 10-100 pmol lfor PGE2 and PGF2a (Fig. la,b) , 30-100 pmol 1 for cate¬ cholamines (Fig. Id) , 100 pmol 1_1 for forskolin (Fig. lc) proliferative phase (Bergamini et al, 1985) . Vilar-Rojas et al. (1982) reported that in rats endometrial cAMP concentrations and cGMP concentrations were higher at the implantation site than at other sites. Kennedy (1983) (Singh el al, 1975) . The adrenaline concentration in the whole uterus, however, is high during the proliferative phase (Dujovne et al, 1976 (Lumsden et al, 1984) . Fortier et al. (1987 Fortier et al. ( , 1990 tube is innervated by adrenergic nerve fibres along its entire length (Brundin and Wirsen, 1964) . Alpha-and beta-adrenergic receptors mediating changes in resting pressure (Rosenblum and Stein, 1966) and motility (Nakanishi et al, 1967) 
